UNSPSC 51343108: Fialuridine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H10FIN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 53T7IN77LC, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodo- but generally known as fialuridine, which bears US NIH Compound Identifier 50313. European Medicines Agency schedules Fialuridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07622MIG.

UNSPSC 51343108 Fialuridine, a Commodity code, represents pharmaceutical products and related medical supplies that state and local governments procure through cooperative purchasing vehicles and direct awards. Recent state and local activity under this code shows procurement of both specialty pharmaceuticals and emergency-response medical supplies, though the opportunities posted do not strictly align with fialuridine itself — the code appears to serve as a broader catchall for pharmaceutical and medical-supply procurement within state health and safety contexts. State and local issuing bodies soliciting under this code include state health departments and county public-health or emergency-services agencies. The Illinois Department of Public Health and Seminole County, Florida represent the active buyers in the recent record, each pursuing different product categories within the pharmaceutical-supply space.

Geographic activity centers on Illinois and Florida based on recent postings. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse cooperative to Chartwell Rx LLC on August 28, 2026, valued at $2,999,999.11 over three years, for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under IFB 26-482DPH-PREPD-B-53392. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026, with a response deadline of July 26, 2026, for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. Both procurements use competitive bidding processes and cooperative or direct-award structures rather than open-market RFPs, with delivery and insurance compliance as standard requirements.